US Stock MarketDetailed Quotes
AEMD Aethlon Medical
- 1.3600
- -0.1430-9.51%
Close Apr 26 16:00 ET
- 1.3500
- -0.0100-0.74%
Post 16:29 ET
3.58MMarket Cap-271P/E (TTM)
1.5000High1.3300Low19.77KVolume1.5000Open1.5030Pre Close27.89KTurnover0.82%Turnover RatioLossP/E (Static)2.63MShares5.000052wk High0.47P/B3.30MFloat Cap1.330052wk Low--Dividend TTM2.42MShs Float67499.9865Historical High--Div YieldTTM11.31%Amplitude1.3300Historical Low1.4100Avg Price1Lot Size
Aethlon Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -21.87%-2.38M | 6.05%-2.7M | 9.03%-2.48M | -7.56%-10.51M | 4.92%-2.95M | 28.22%-1.95M | -53.26%-2.88M | -31.72%-2.73M | -44.38%-9.77M | -38.44%-3.1M |
| Net income from continuing operations | -21.72%-3.47M | 20.34%-3.03M | -12.94%-3.28M | -15.44%-12.03M | 34.84%-2.47M | -12.65%-2.85M | -89.62%-3.81M | -38.49%-2.91M | -32.05%-10.42M | -67.17%-3.79M |
| Operating gains losses | ---- | ---- | ---- | --142.12K | --0 | --0 | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 17.08%91.47K | 73.90%91.43K | 194.70%90.33K | 94.76%240.89K | 214.12%79.54K | 342.06%78.13K | -23.83%52.57K | 162.73%30.65K | 209.68%123.69K | 126.82%25.32K |
| Other non cash items | -104.12%-566 | -62.58%686 | -84.13%1.24K | -20.06%24.41K | -95.09%1.02K | 15.59%13.75K | 264.69%1.83K | 831.02%7.8K | 1,325.69%30.53K | 2,810.29%20.82K |
| Change In working capital | -22.31%421.15K | -104.51%-18.98K | 697.10%458.12K | 126.02%65.34K | -299.14%-820.66K | 228.83%542.08K | 404.14%420.64K | 26.33%-76.72K | -181.08%-251.11K | 406.01%412.1K |
| -Change in receivables | --0 | --0 | --0 | 505.98%127.97K | --0 | --114.85K | --0 | -23.37%13.12K | -63.37%21.12K | 111.69%4K |
| -Change in prepaid assets | -62.86%40.78K | 27.49%95K | 47.39%146.41K | 162.54%398.17K | 141.97%114.52K | 123.74%109.79K | 4,012.58%74.52K | 2.45%99.34K | -471.14%-636.69K | -2.88%-272.9K |
| -Change in payables and accrued expense | 19.82%380.37K | -149.29%-113.99K | 202.53%311.71K | -186.26%-116.25K | -163.75%-360.94K | 534.55%317.44K | 265.06%231.27K | -39.32%-304.02K | -61.35%134.76K | 1,033.00%566.15K |
| -Change in other working capital | ---- | ---- | ---- | -250.00%-344.55K | -600.00%-574.25K | --0 | --114.85K | --114.85K | 1,446.89%229.7K | 0.00%114.85K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -21.87%-2.38M | 6.05%-2.7M | 9.03%-2.48M | -7.56%-10.51M | 4.92%-2.95M | 28.22%-1.95M | -53.26%-2.88M | -31.72%-2.73M | -44.38%-9.77M | -38.44%-3.1M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K | -1,725.68%-739.17K | -7.28%-41.17K | -483.14%-349.19K | -3,944.91%-212.4K |
| Net PPE purchase and sale | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K | -1,725.68%-739.17K | -7.28%-41.17K | -483.14%-349.19K | -3,944.91%-212.4K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 94.19%-8.81K | 99.08%-6.77K | -459.60%-230.38K | -170.08%-943.11K | 94.68%-11.29K | -161.48%-151.49K | -1,725.68%-739.17K | -7.28%-41.17K | -483.14%-349.19K | -3,944.91%-212.4K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 9,501.75%177.13K | -100.12%-9.84K | 73.99%1.08M | -48.67%8.91M | 75.23%-2.64K | 86.10%-1.88K | 29,600.95%8.3M | -96.44%619.44K | 143.65%17.37M | 59.29%-10.64K |
| Net common stock issuance | --186.5K | --0 | 75.34%1.09M | -48.86%8.93M | --0 | --0 | --8.31M | -96.45%619.44K | 140.41%17.46M | --0 |
| Net other financing activities | -397.51%-9.37K | ---9.84K | ---8.37K | 85.82%-12.49K | 75.23%-2.64K | 86.10%-1.88K | ---- | ---- | 33.51%-88.12K | 59.29%-10.64K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 9,501.75%177.13K | -100.12%-9.84K | 73.99%1.08M | -48.67%8.91M | 75.23%-2.64K | 86.10%-1.88K | 29,600.95%8.3M | -96.44%619.44K | 143.65%17.37M | 59.29%-10.64K |
| Net cash flow | ||||||||||
| Beginning cash position | -47.88%10.26M | -13.49%12.99M | -14.80%14.62M | 73.19%17.16M | -14.13%17.59M | -15.38%19.69M | -40.48%15.01M | 73.19%17.16M | 3.16%9.91M | 68.18%20.48M |
| Current changes in cash | -4.99%-2.21M | -158.11%-2.72M | 23.98%-1.64M | -135.02%-2.54M | 10.70%-2.97M | 24.56%-2.1M | 340.52%4.68M | -114.05%-2.15M | 2,289.17%7.25M | -46.35%-3.32M |
| Effect of exchange rate changes | --5.61K | ---1.06K | ---186 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| End cash Position | -54.17%8.06M | -47.88%10.26M | -13.49%12.99M | -14.80%14.62M | -14.80%14.62M | -14.13%17.59M | -15.38%19.69M | -40.48%15.01M | 73.19%17.16M | 73.19%17.16M |
| Free cash flow | -13.51%-2.39M | 25.06%-2.71M | 2.07%-2.71M | -13.17%-11.45M | 10.67%-2.96M | 24.26%-2.1M | -88.55%-3.62M | -31.27%-2.77M | -48.23%-10.12M | -47.58%-3.31M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg